Orthoptists
29-1299.02Median wage $115,210/yr28,630 employed (US)Rank #710 of 923 scored · top 77% by substitution
Diagnose and treat visual system disorders such as binocular vision and eye movement impairments.
Sub-scores
0–100 · band = confidence interval from rater disagreement
Substitution19
Exposure19
Augmentation55
Substitution — the headline: capability discounted by cost, barriers and adoption.
Exposure — technical capability alone, regardless of whether anyone deploys it.
Augmentation — how much AI assists without replacing. High here + moderate substitution = a changing job, not a disappearing one.
Tasks on the substitution scale
16 rated tasks, binned by substitution score.
Position among all scored occupations
Distribution of 923 occupation scores; the marker is this occupation.
Tasks with substitution ≥ 70
0%
Run 1.0.0-draft.1 · computed 2026-08-05 · rater panel: claude-sonnet-5, claude-haiku-4-5-20251001 · intervals span rater disagreement.
Why this score
The five weighted dimensions of the composite, averaged across this occupation's tasks (importance-weighted, panel mean). Exact weights and formulas: /api/v1/methodology.
Task automatabilityw 35%19
panel mean rating 1.8/5 → substitution pressure 19/100
Technical feasibility todayw 20%18
panel mean rating 1.7/5 → substitution pressure 18/100
Cost vs. human wagew 15%18
panel mean rating 1.7/5 → substitution pressure 18/100
Adoption barriersw 20%inverted — strong barriers lower the score19
panel mean rating 4.2/5 (barrier strength) → substitution pressure 19/100
Sector adoption velocityw 10%20
panel mean rating 1.8/5 → substitution pressure 20/100
Task breakdown (16 tasks)
Substitution pressure per task, weighted by O*NET importance in the composite. Expand a task for the full rater audit trail — every rating, every model, every rationale.
Prepare diagnostic or treatment reports for other medical practitioners or therapists.
34CI 25–43 · exposure 33 · augmentation 63 · importance 4.0/5 · click for rater detail
Prepare diagnostic or treatment reports for other medical practitioners or therapists.
34| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Healthcare sectors digitize slowly and conservatively; orthoptics is a smaller specialty with lower IT investment than larger medical fields. Adoption of AI documentation tools in orthoptic practice remains in pilot or early stages, with most practitioners still relying on traditional human-written reports. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare documentation AI is spreading in large hospital systems but orthoptics is a small, specialized niche with slower uptake of tailored AI tools. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can assist by auto-populating template fields, suggesting report structure, and drafting routine sections based on examination data, improving orthoptist productivity. However, the clinical complexity and liability risk limit the depth of augmentation compared to higher-risk-tolerance domains. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI can meaningfully speed up drafting of diagnostic summaries and standardize report language, letting orthoptists focus on clinical interpretation and patient care. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | Report writing requires synthesis of clinical examination data, patient history, and treatment decisions—tasks partially automatable with structured templates and data extraction. However, the medical judgment, interpretation of findings, and clinical reasoning needed to select appropriate content and framing remain difficult for current AI without significant human oversight and revision. |
| Task automatability | claude-sonnet-5 | 3/5 | Drafting structured reports from exam findings and clinical notes is a language-generation task well within current LLM capability, but requires accurate integration of clinical data and orthoptic-specific terminology, limiting full automation without human review. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Orthoptic reports must be signed by a licensed orthoptist and often by referring physicians; regulatory and liability requirements mandate human clinical judgment and accountability. Most healthcare organizations require human verification and signature, creating hard barriers to unsupervised automation. |
| Adoption barriers | claude-sonnet-5 | 3/5 | While a licensed orthoptist or ophthalmologist must ultimately verify and sign off on the report, drafting itself is not restricted by licensure, creating moderate but not hard barriers. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | AI drafting tools reduce typing time but require extensive human review, fact-checking, and revision by a licensed orthoptist. When accounting for oversight burden and the need to correct clinical inaccuracies, all-in cost savings are modest and may not exceed the loaded wage of the practitioner reviewing and validating the output. |
| Cost vs. human wage | claude-sonnet-5 | 3/5 | AI drafting tools could cut report-writing time substantially, but licensing, integration with ophthalmic diagnostic systems, and required clinician review keep overall costs only moderately below fully manual reporting. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | While AI can draft sections of medical reports using templates and extracted data, deployed clinical documentation systems show material error rates in terminology, clinical accuracy, and liability exposure. No production system reliably generates standalone orthoptic reports without substantial physician review and editing. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | General clinical documentation AI (e.g., ambient scribes, EHR-integrated summarizers) exists but specialized orthoptic diagnostic reporting products are not widely deployed or validated in production settings. |
Present or publish scientific papers.
32CI 25–39 · exposure 33 · augmentation 75 · importance 3.5/5 · click for rater detail
Present or publish scientific papers.
32| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Academic and clinical research sectors show limited actual adoption of AI for autonomous scientific paper writing; most adoption remains in assistive editing and formatting roles, not end-to-end generation. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare and allied health professions, including orthoptics, show slower AI adoption for research writing and presentation tasks compared to fields like software or finance, with mostly pilot-level use of AI writing aids. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI tools meaningfully assist orthoptists in literature review, drafting sections, organizing citations, and copyediting, substantially raising productivity while the researcher retains full intellectual control and responsibility. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI tools substantially assist with literature review, drafting, editing, formatting citations, and creating presentation slides, meaningfully boosting productivity while the orthoptist retains authorship and scientific responsibility. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | Writing and publishing scientific papers require domain expertise, original research synthesis, narrative coherence, and understanding of journal conventions—tasks that exceed current AI capabilities. While AI can assist with drafting sections and editing, the core intellectual work of formulating findings, interpreting results, and arguing novelty demands human authorship and accountability. |
| Task automatability | claude-sonnet-5 | 3/5 | AI can draft scientific text, summarize data, and generate slides, but final scientific writing requires domain expertise, original research judgment, and accuracy verification that current tools cannot fully replace end-to-end.atelet |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Institutional and ethical barriers are substantial: authorship requires accountability for research integrity, journals require author signatures attesting to originality, and institutional review boards scrutinize research conduct. Regulatory and professional norms mandate human responsibility over AI-generated content. |
| Adoption barriers | claude-sonnet-5 | 3/5 | Scientific publication requires named authorship, accountability for accuracy, and often peer review and ethical approval, creating moderate barriers to full automation despite no explicit licensing requirement for the task itself. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | The cost of using AI writing assistants plus the required human expert review and revision is comparable to or potentially higher than having a skilled orthoptist researcher write directly, given the quality bar for publication. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | While drafting tools are cheap, the human orthoptist's time for research design, data interpretation, and presenting still dominates, so overall cost savings versus a human researcher are modest. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | No deployed product reliably performs end-to-end scientific paper writing for publication. AI tools exist for drafting assistance and formatting, but production systems still require substantial human oversight, rewriting, and expertise to meet journal standards and accuracy requirements. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Writing assistants and slide generators are used to help draft manuscripts and presentations, but no deployed product reliably produces publishable scientific papers or delivers presentations autonomously in orthoptics or clinical research settings. |
Perform vision screening of children in schools or community health centers.
28CI 25–30 · exposure 25 · augmentation 50 · importance 3.5/5 · click for rater detail
Perform vision screening of children in schools or community health centers.
28| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | School and community health screening programs remain largely manual and traditional in execution; digitization and AI adoption are nascent, with most programs still reliant on portable screening equipment and human technicians rather than technology-driven systems. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare and school-based community health screening are traditionally slow-adopting sectors for AI-driven physical/clinical tasks, with automated screening tools present but not yet displacing human screeners broadly. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI could assist orthoptists by automating preliminary acuity measurement, flagging potential abnormalities in visual behavior recordings, or organizing test results, thereby allowing the clinician to focus on behavioral assessment and clinical decision-making with children. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI-enabled screening devices and image analysis tools can assist orthoptists by flagging cases and speeding up data capture, improving throughput while the professional still manages the encounter. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | Vision screening involves visual acuity assessment and basic orthoptic testing that could be partially automated through image analysis and pupillary response measurement, but the task requires dynamic assessment of children, behavioral observation, and clinical judgment that current AI cannot fully replicate. End-to-end automation with ≥50% time savings at equal quality is not yet feasible with off-the-shelf systems. |
| Task automatability | claude-sonnet-5 | 2/5 | Some automated vision screening devices exist and can capture data, but interpreting results, interacting with children, and administering the full screening process still requires human clinical judgment and physical presence. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Pediatric vision screening in schools often requires trained clinical personnel or licensed optometrists/orthoptists to ensure legal compliance, referral protocols, and parental consent. Liability for missed conditions and regulatory requirements for clinical data handling create meaningful adoption barriers. |
| Adoption barriers | claude-sonnet-5 | 3/5 | While screening itself isn't as tightly regulated as diagnosis, clinical protocols, working with vulnerable populations (children), and referral/liability concerns create moderate barriers to full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Deploying AI-based vision screening infrastructure (cameras, software, training, oversight) per child in schools or clinics requires significant upfront capital and integration costs that approach or exceed the cost of trained orthoptists for routine screening tasks. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Screening devices reduce some labor cost but still require a trained operator, equipment investment, and referral pathways, so total cost is not dramatically below human-only screening at scale. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | While AI tools exist for basic visual acuity detection from images and some eye condition screening, no deployed product reliably performs comprehensive pediatric vision screening independently in school or community settings. Current systems lack the interactivity and adaptability required for uncooperative pediatric patients and integration into clinical workflows remains immature. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Automated vision screening devices (e.g., photoscreeners) are deployed in some school programs, but they are narrow tools requiring trained operators and follow-up clinical evaluation, not full end-to-end AI systems replacing the orthoptist. |
Provide instructions to patients or family members concerning diagnoses or treatment plans.
25CI 25–25 · exposure 25 · augmentation 63 · importance 5.0/5 · click for rater detail
Provide instructions to patients or family members concerning diagnoses or treatment plans.
25| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Healthcare adoption of AI for direct patient communication is slow and cautious; most orthoptic practices remain traditional in patient interaction, with limited production deployment of autonomous patient instruction systems. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare, especially allied specialties like orthoptics, has been slow to adopt AI-driven patient communication tools compared to more digitized sectors like finance or general information services. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can assist by drafting personalized instruction summaries, generating visual aids, or preparing supplementary materials that the orthoptist reviews and personalizes—moderately useful support that enhances clarity without removing the practitioner from the core communication task. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI can meaningfully assist orthoptists by drafting patient-friendly explanations, summarizing treatment plans, and generating multilingual or literacy-adjusted materials, improving efficiency and clarity while the clinician remains responsible for final communication. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI can generate patient education materials and draft instruction text, the task requires personalized communication adapted to individual patient circumstances, comprehension levels, and emotional context. Current AI cannot reliably navigate the nuanced, interactive nature of patient instruction to meet the ≥50% time-saving threshold while maintaining quality. |
| Task automatability | claude-sonnet-5 | 2/5 | AI can draft explanatory text about diagnoses or treatment plans, but delivering it in-person, answering follow-up questions, and adapting to patient understanding and emotional state requires human judgment and interaction that current systems cannot fully replace. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Strong regulatory and liability barriers protect this task: the orthoptist must legally document informed consent, diagnosis explanation, and treatment instructions; patients expect and often prefer in-person clinical guidance; and malpractice risk discourages full automation without human sign-off. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Communicating diagnoses and treatment plans is generally considered part of licensed clinical practice with liability implications, so a qualified provider typically must be involved in confirming or delivering this information. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Integration costs for compliant patient communication systems, plus required human oversight for accuracy and liability, roughly match or exceed the cost of having an orthoptist deliver instruction directly; no cost advantage materializes. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | While AI-generated educational content is cheap, the actual counseling task still requires clinician time for verification, personalization, and liability, keeping overall cost comparable to human-only delivery. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | No deployed product reliably performs patient instruction delivery end-to-end; AI chatbots and scripted systems exist but lack the ability to assess patient understanding, adapt dynamically, and handle complex clinical scenarios that orthoptists encounter in practice. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Chatbots and patient portals can provide generic educational materials, but no deployed product reliably delivers personalized clinical instructions for orthoptic diagnoses/treatment at the point of care. |
Interpret clinical or diagnostic test results.
25CI 25–25 · exposure 25 · augmentation 50 · importance 4.7/5 · click for rater detail
Interpret clinical or diagnostic test results.
25| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Adoption of AI for clinical interpretation in orthoptics remains slow; most practices continue to rely on human orthoptists, with AI tools used primarily as assistive second-reads rather than primary decision-makers, limiting real-world displacement. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare diagnostics overall show slow, cautious AI adoption due to regulatory approval processes, and orthoptics is a narrow specialty with limited AI tool development compared to broader ophthalmology or radiology. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can meaningfully assist by highlighting patterns, flagging abnormalities, and organizing test data for faster review, raising orthoptist efficiency on interpretation tasks while they retain clinical judgment and responsibility for final calls. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI can assist by flagging abnormal patterns in imaging or visual field data, helping orthoptists prioritize and cross-check findings, though the core interpretive judgment remains human-led. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI can assist with pattern recognition in clinical test data, orthoptic interpretation requires contextual judgment about patient history, test quality, and clinical correlation that current systems struggle with end-to-end. AI might accelerate data extraction but cannot reliably replace the full diagnostic reasoning at the required quality threshold. |
| Task automatability | claude-sonnet-5 | 2/5 | Interpreting orthoptic diagnostic results (e.g., strabismus measurements, visual field tests, ocular motility) requires integrating clinical context and nuanced visual judgment that current AI cannot fully replicate end-to-end.But AI can assist with pattern flagging on standardized tests like visual fields.It falls short of the 50% time-saving-at-equal-quality bar for the full interpretive task. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Regulatory requirements (clinical validity standards, liability for misinterpretation), professional licensing expectations, and clinical governance frameworks create strong barriers—a licensed orthoptist must typically review and sign off on diagnostic interpretations for patient care and medical-legal purposes. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Clinical diagnostic interpretation in this licensed allied health profession typically requires the orthoptist or ophthalmologist to formally sign off, given liability and patient safety concerns. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Current AI systems for clinical interpretation require substantial backend infrastructure, human oversight for accuracy validation, and integration costs that approach or exceed the cost of employing an orthoptist for this task, especially in lower-volume practices. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Specialized diagnostic interpretation software requires significant integration, validation, and clinician oversight, making costs comparable to or only modestly cheaper than human orthoptist time for this narrow task. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | Diagnostic AI tools exist for narrow domains (e.g., retinal imaging), but deployed products for comprehensive orthoptic test interpretation remain limited and typically flag results for human review rather than independently interpreting them reliably in production settings. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | Some AI-assisted diagnostic tools exist for ophthalmic imaging (e.g., OCT, retinal screening), but few are validated specifically for orthoptic assessments like strabismus or binocular vision testing in production clinical settings. |
Assist ophthalmologists in diagnostic ophthalmic procedures, such as ultrasonography, fundus photography, and tonometry.
25CI 25–25 · exposure 25 · augmentation 63 · importance 3.1/5 · click for rater detail
Assist ophthalmologists in diagnostic ophthalmic procedures, such as ultrasonography, fundus photography, and tonometry.
25| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Adoption of AI diagnostic aids in ophthalmology is emerging but still predominantly in research and pilot settings at major academic centers; widespread clinical deployment in routine practice remains limited, particularly in smaller and rural practices. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare, especially allied health procedural roles, adopts AI more slowly than digital-native sectors due to regulatory approval processes, though AI-assisted diagnostic imaging is gaining some traction in ophthalmology specifically. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can meaningfully assist orthoptists in image analysis and flagging abnormalities (e.g., AI-aided fundus screening), raising productivity on interpretation tasks, but the hands-on procedural and patient-interaction components limit transformative augmentation of the full role. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI can meaningfully augment orthoptists by pre-screening fundus images, flagging abnormalities, and assisting with measurement analysis, improving efficiency and diagnostic accuracy while the human remains central to the procedure. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI can assist with image analysis (e.g., fundus photo interpretation), the task requires hands-on patient interaction, equipment operation, and real-time procedural assistance that cannot be fully automated end-to-end today. Image interpretation alone does not meet the 50% time-saving threshold for the complete diagnostic assistance role. |
| Task automatability | claude-sonnet-5 | 2/5 | AI can assist with image analysis (e.g., fundus photo interpretation) but the hands-on procedural work of positioning patients, operating ultrasonography and tonometry equipment, and coordinating with ophthalmologists requires physical presence and clinical judgment that current AI cannot replicate end-to-end. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Orthoptists operate under scope-of-practice regulations in most jurisdictions, and diagnostic procedures often require direct patient contact and professional licensure; ophthalmologists typically remain legally responsible for diagnostic decisions, creating strong regulatory and liability barriers to full automation. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Ophthalmic diagnostic procedures are performed under clinical licensure and regulatory oversight, with liability concerns and requirements for trained personnel to operate equipment and interact with patients, creating substantial barriers to full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | AI image analysis tools have low marginal cost, but integrating them into clinical workflows and maintaining required human oversight makes the all-in cost still substantial relative to the specialized labor being assisted, particularly given liability and quality assurance needs. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | While AI image analysis software is cheap per image, it doesn't replace the orthoptist's physical task execution, equipment operation, and patient interaction, so overall cost savings versus the human professional are limited. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | AI products exist for fundus image analysis and some diagnostic support, but clinical deployment remains limited and requires ophthalmologist oversight; no mature system reliably performs the full suite of orthoptist diagnostic assistance independently in routine practice. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | AI-based diagnostic image analysis tools (e.g., for diabetic retinopathy screening) exist in production, but no deployed product performs the full assistive role of an orthoptist conducting these procedures alongside a physician. |
Develop or use special test and communication techniques to facilitate diagnosis and treatment of children or patients with disabilities.
24CI 0–47 · exposure 33 · augmentation 50 · importance 4.6/5 · click for rater detail
Develop or use special test and communication techniques to facilitate diagnosis and treatment of children or patients with disabilities.
24| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Orthoptics is a specialized healthcare field with slower digital transformation than general medicine; most practices remain small, clinic-based, and focused on direct patient interaction. Adoption of AI diagnostic aids is pilot-stage in most regions, not yet mainstream in production workflows. |
| Sector adoption velocity | claude-sonnet-5 | 1/5 | Clinical vision therapy for disabled populations is a small, highly specialized, low-digitization niche with minimal AI deployment. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI can substantially augment orthoptists by automating routine assessment documentation, generating communication templates tailored to patient type, flagging atypical test results, and supporting protocol adherence—allowing clinicians to focus on adaptive interaction and clinical reasoning while AI handles data capture and preliminary screening. |
| Augmentation potential | claude-sonnet-5 | 2/5 | AI could help with documentation or scheduling, but offers little direct assistance in the specialized testing and communication techniques themselves. |
| Task automatability | claude-haiku-4-5-20251001 | 4/5 | AI can automate substantial portions of this task through diagnostic screening, test administration, and communication protocol generation. However, the nuanced interaction with children or disabled patients, real-time behavioral adaptation, and clinical judgment required for safe practice prevent full end-to-end automation, though 50% time savings are achievable via AI-assisted assessment tools and pre-populated treatment plans. |
| Task automatability | claude-sonnet-5 | 1/5 | This requires hands-on clinical examination, adaptive communication with disabled or pediatric patients, and real-time judgment that current AI cannot perform end-to-end. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Strong regulatory barriers exist: orthoptists are licensed professionals whose diagnostic and treatment recommendations carry clinical liability; patients with disabilities often require legally-mandated informed consent and human-led care plans. Liability asymmetry and professional licensure strongly protect this task from full substitution. |
| Adoption barriers | claude-sonnet-5 | 5/5 | Orthoptic diagnosis and treatment for disabled patients requires a licensed clinician, involves liability for misdiagnosis, and mandates direct human interaction and adaptation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Integration of AI assistance tools, oversight infrastructure, and required clinician supervision increase operational costs; savings from reduced administrative time do not yet offset the full loaded cost of the human orthoptist performing direct patient evaluation and adaptive communication. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | There is no AI substitute performing this task, so no favorable cost comparison exists; a human specialist is required. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 3/5 | Products exist (speech-to-text for accessibility, diagnostic questionnaire systems, some telehealth platforms with structured protocols), but they operate in narrow scope and require clinician oversight. No mature, fully deployed AI system reliably replicates the adaptive communication and specialized testing techniques required across diverse disability presentations in production orthoptic settings. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed product performs orthoptic testing or adapted communication for disabled patients; this remains firmly a hands-on clinical skill. |
Collaborate with ophthalmologists, optometrists, or other specialists in the diagnosis, treatment, or management of conditions such as glaucoma, cataracts, and retinal diseases.
18CI 3–34 · exposure 20 · augmentation 63 · importance 3.9/5 · click for rater detail
Collaborate with ophthalmologists, optometrists, or other specialists in the diagnosis, treatment, or management of conditions such as glaucoma, cataracts, and retinal diseases.
18| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Adoption of AI-assisted diagnostic tools in ophthalmology is growing but remains patchy; most practices are in early pilot phases and many clinicians remain skeptical of delegating judgment in specialist collaboration to automated systems, limiting rapid deployment. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare, especially specialized clinical diagnosis and interdisciplinary care, adopts AI cautiously due to regulatory oversight, liability, and the need for licensed professional judgment. |
| Augmentation potential | claude-haiku-4-5-20251001 | 4/5 | AI can substantially enhance orthoptist productivity by automating image preprocessing, flagging anomalies in retinal or optic nerve imaging, and suggesting diagnostic possibilities, allowing the specialist to focus on clinical reasoning and team communication rather than manual screening. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI diagnostic imaging tools (e.g., retinal scan analysis) can assist specialists in identifying disease markers, supporting but not replacing the collaborative diagnostic and management process. |
| Task automatability | claude-haiku-4-5-20251001 | 3/5 | Segments of this task such as processing and summarizing patient histories, flagging diagnostic patterns in imaging results, and drafting collaborative notes could be automated with 50%+ time savings using AI; however, the core requirement for clinical expertise in diagnosis and specialist-level decision-making during multidisciplinary collaboration remains human-centered and difficult to fully automate. |
| Task automatability | claude-sonnet-5 | 1/5 | This task is fundamentally interpersonal and clinical collaboration requiring physical exams, judgment, and real-time interdisciplinary communication; no AI system performs this end-to-end today. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Strong regulatory and liability barriers apply: ophthalmologists and orthoptists are licensed professionals whose diagnostic and treatment decisions carry legal accountability; malpractice liability and patient safety requirements mean humans must retain clinical authority and sign off on all care decisions. |
| Adoption barriers | claude-sonnet-5 | 5/5 | Diagnosis and management of eye diseases requires licensed medical professionals, with strict scope-of-practice laws, liability requirements, and mandatory human sign-off on clinical decisions. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | AI tools for diagnostic support are increasingly affordable, but integrating them into specialist workflows and maintaining oversight adds overhead; total cost savings remain modest compared to the loaded wage of specialized clinicians who must direct and validate the collaboration. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | There is no AI product performing this collaborative clinical role, so no meaningful cost comparison exists; human clinicians remain the only option. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | While clinical AI tools exist for imaging analysis and diagnostic support, no deployed system reliably handles the collaborative judgment and treatment planning across multiple specialties that this task demands; most systems operate as narrow decision-aids rather than end-to-end collaboration partners. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed product substitutes for the collaborative clinical decision-making between orthoptists and other eye specialists; AI diagnostic tools exist but do not replace this coordination role. |
Refer patients to ophthalmic surgeons or other physicians.
16CI 6–25 · exposure 13 · augmentation 50 · importance 4.0/5 · click for rater detail
Refer patients to ophthalmic surgeons or other physicians.
16| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Healthcare adoption of autonomous clinical decision-making is slow due to liability, regulatory scrutiny, and entrenched workflows; AI is typically deployed as a decision-support aid rather than replacement in this setting. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare, especially specialized allied health fields like orthoptics, shows slow AI adoption for clinical decision tasks due to regulatory and liability constraints. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can assist by flagging potential referral candidates, summarizing patient data, and preparing documentation, meaningfully supporting the orthoptist's efficiency without removing human decision-making from the process. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI can help by flagging abnormal findings, suggesting urgency levels, or drafting referral letters, but the clinician still owns the decision and communication. |
| Task automatability | claude-haiku-4-5-20251001 | 1/5 | Referral decisions require clinical judgment about when a patient's condition warrants specialist intervention, integrating patient history, examination findings, and complex risk assessment that current AI cannot reliably perform end-to-end. |
| Task automatability | claude-sonnet-5 | 2/5 | Referral decisions require clinical judgment integrating exam findings, patient history, and urgency assessment that current AI cannot reliably perform end-to-end without clinician oversight.' |
| Adoption barriers | claude-haiku-4-5-20251001 | 5/5 | Legal and regulatory requirements mandate that a licensed healthcare professional must assess the patient and authorize referrals; licensing, liability, and the physician-patient relationship create hard barriers to automation. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Referral is a clinical act tied to licensed scope of practice and liability for missed or inappropriate referrals, making a human professional's accountability essentially required. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | AI tools for decision support may reduce some documentation overhead, but the core referral decision still requires a licensed orthoptist's time, making full cost replacement infeasible. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | Since AI cannot independently perform the referral decision, any deployment still requires the orthoptist's time and judgment, so cost savings are minimal relative to human labor. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | While AI systems can help identify candidates for referral through pattern recognition, no deployed product reliably makes autonomous referral decisions; clinical validation and human oversight remain mandatory in real practice. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed product autonomously makes referral decisions and executes referrals to surgeons; this remains a clinician-driven decision task, at most supported by EHR workflow tools. |
Evaluate, diagnose, or treat disorders of the visual system with an emphasis on binocular vision or abnormal eye movements.
14CI 3–25 · exposure 13 · augmentation 50 · importance 5.0/5 · click for rater detail
Evaluate, diagnose, or treat disorders of the visual system with an emphasis on binocular vision or abnormal eye movements.
14| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Adoption of AI in orthoptics and binocular vision clinics remains limited; most practices operate in slower-adopting healthcare settings with legacy systems. While larger academic medical centers may pilot tools, production deployment of AI-driven diagnosis and treatment in this specialty is still rare. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare broadly adopts AI slowly for diagnostic tasks due to regulatory and liability constraints, and this specialized physical-exam-based subfield sees minimal AI deployment. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can meaningfully assist orthoptists by automating routine eye movement measurement analysis, flagging anomalies in imaging data, and generating preliminary diagnostic summaries, allowing clinicians to focus on treatment planning and patient interaction. However, the augmentation is partial rather than transformative given the judgment-heavy nature of binocular vision disorders. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI-assisted image analysis and decision-support tools can help interpret certain ocular imaging or track eye movement data, offering moderate assistance while the orthoptist performs the core clinical evaluation. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI can assist with image analysis and pattern recognition in diagnostic data, the task requires comprehensive clinical judgment integrating multiple data streams (patient history, visual function tests, eye movement tracking, neurological correlates) and real-time patient interaction to diagnose and treat complex binocular vision disorders. Current AI lacks the end-to-end capability to replace an orthoptist's diagnostic reasoning and treatment planning at the ≥50% time-saving threshold. |
| Task automatability | claude-sonnet-5 | 1/5 | This requires hands-on clinical examination (cover tests, ocular motility assessment, prism measurements) and integrated diagnostic judgment that current AI cannot perform end-to-end without a clinician physically present. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Orthoptists operate under healthcare licensing and regulatory frameworks; diagnosis and treatment carry liability and error-cost asymmetries; clinical decisions often require direct patient interaction and sign-off by licensed practitioners. Regulatory bodies and standard of care embed human accountability, creating substantial adoption friction. |
| Adoption barriers | claude-sonnet-5 | 5/5 | This is a licensed clinical activity requiring a credentialed orthoptist or ophthalmologist, with direct patient contact, physical examination, and legal accountability for diagnosis and treatment. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | The infrastructure, validation, clinical oversight, and integration costs of AI diagnostics for binocular vision disorders remain substantial, and the human orthoptist's loaded wage for a specialized clinical role is relatively modest per task. AI cost parity or advantage is not yet demonstrated in practice. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | There is no viable AI substitute performing this full clinical task, so cost comparison favors the human orthoptist by default since no AI alternative exists at scale. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | AI tools exist for narrower components (e.g., automated eye movement analysis, image classification of certain conditions) but no deployed product reliably performs the full diagnostic and treatment workflow independently. Existing systems require significant human oversight and are limited in scope, falling short of production-grade reliability for the complete task. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed product independently evaluates, diagnoses, or treats binocular vision or eye movement disorders; AI tools in ophthalmology are limited to narrow imaging analysis, not full clinical assessment. |
Participate in clinical research projects.
14CI 3–25 · exposure 13 · augmentation 63 · importance 3.3/5 · click for rater detail
Participate in clinical research projects.
14| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Healthcare research lags in automation adoption; research coordination tools exist but do not displace human investigators. Regulatory constraints and liability concerns slow meaningful AI substitution in this domain. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare research settings are cautious adopters of AI due to regulatory, ethical, and data privacy concerns, with pilots more common than production deployment. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can assist orthoptists with literature searches, data management, statistical summaries, and adverse event flagging, modestly improving research efficiency while the human retains full decision-making authority. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI tools significantly assist literature reviews, data analysis, statistical modeling, and drafting manuscripts, meaningfully boosting researcher productivity while humans retain oversight. |
| Task automatability | claude-haiku-4-5-20251001 | 1/5 | Clinical research participation requires human judgment in patient consent, protocol adherence, adverse event reporting, and ethical decision-making that cannot be automated end-to-end today. AI cannot meaningfully replace the human investigator's role in enrolling subjects, conducting assessments, or interpreting safety signals. |
| Task automatability | claude-sonnet-5 | 2/5 | Clinical research involves study design, patient recruitment, ethical oversight, and interpretation of clinical context that AI cannot autonomously execute, though it can assist with sub-components like literature review or data analysis.mand |
| Adoption barriers | claude-haiku-4-5-20251001 | 5/5 | Clinical research is heavily regulated by institutional review boards (IRBs), FDA rules, and Good Clinical Practice (GCP) standards that mandate human investigator accountability, informed consent delivery, and adverse event reporting signed by a licensed professional. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Clinical research requires human oversight for ethical approval, patient safety, professional accountability, and regulatory compliance (IRB/ethics boards), creating strong barriers to full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 1/5 | AI cannot substitute for the licensed orthoptist's clinical judgment and regulatory accountability in research; the human remains mandatory. The cost of AI infrastructure for partial support does not offset the irreplaceable human labor. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | While AI can cheaply assist with data crunching or drafting, the overall research task still requires costly human expertise, IRB compliance, and clinical judgment, keeping the human-AI cost comparison close. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 1/5 | No deployed AI product reliably performs clinical research participation tasks independently. Research coordination, ethics review, and patient safety oversight remain human-driven; AI tools assist with data management but do not conduct research activities themselves. |
| Technical feasibility today | claude-sonnet-5 | 2/5 | AI tools exist for literature synthesis and statistical analysis but no deployed product manages end-to-end clinical research participation for orthoptists in production settings. |
Examine patients with problems related to ocular motility, binocular vision, amblyopia, or strabismus.
13CI 0–25 · exposure 13 · augmentation 50 · importance 5.0/5 · click for rater detail
Examine patients with problems related to ocular motility, binocular vision, amblyopia, or strabismus.
13| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Orthoptics is a specialized clinical field with limited digitization and slow uptake of AI tools; adoption is largely restricted to research settings and occasional pilot screening programs rather than broad production deployment across the sector. |
| Sector adoption velocity | claude-sonnet-5 | 1/5 | Healthcare diagnostic specialties involving physical exams are slow to adopt full automation; AI use is limited to decision-support pilots, not workflow replacement. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI-assisted image analysis and initial screening can help orthoptists triage patients and focus on complex cases, improving workflow efficiency. However, augmentation is limited to specific subtasks like detecting obvious deviations rather than transforming the full diagnostic process. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI can assist with image analysis, documentation, or flagging abnormal eye movement patterns from video, aiding but not replacing the orthoptist's hands-on assessment. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | Current AI can analyze images and detect some strabismus or obvious motility issues from video, but comprehensive ocular motility assessment requires live clinical judgment, patient interaction, and real-time measurement of eye movements that AI cannot reliably replicate end-to-end today. The task involves subjective clinical decision-making and therapeutic planning that falls well short of 50% time savings at equal quality. |
| Task automatability | claude-sonnet-5 | 1/5 | This requires hands-on clinical examination using specialized equipment (prisms, cover tests, synoptophores) and physical interaction with patients, none of which current AI systems can perform end-to-end. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Clinical examination and diagnosis of strabismus and amblyopia require a licensed orthoptist or optometrist in most jurisdictions, and the task often involves legal liability for missed diagnoses affecting patient care. Regulatory requirements and professional licensing create strong barriers to full AI substitution. |
| Adoption barriers | claude-sonnet-5 | 5/5 | Orthoptic examination is a licensed clinical activity requiring direct patient contact, hands-on testing, and professional judgment with real diagnostic liability. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | AI-based screening or initial triage tools have emerged, but comprehensive AI-driven examination with proper calibration and oversight remains expensive relative to the loaded cost of an orthoptist performing the same task, particularly when factoring in false positives and required human review. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | AI cannot replace the physical examination process, so there is no viable cost comparison for the full task; a human orthoptist remains necessary. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | While AI image analysis tools exist for detecting certain ocular conditions, no deployed product reliably performs the full diagnostic examination of ocular motility, binocular vision, and strabismus as an orthoptist would. Research prototypes show promise but production systems lack the clinical sensitivity and specificity needed for independent diagnosis. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed product performs full orthoptic examinations; AI is at most research-stage for isolated components like image-based strabismus detection. |
Perform diagnostic tests or measurements, such as motor testing, visual acuity testing, lensometry, retinoscopy, and color vision testing.
13CI 0–25 · exposure 13 · augmentation 50 · importance 4.9/5 · click for rater detail
Perform diagnostic tests or measurements, such as motor testing, visual acuity testing, lensometry, retinoscopy, and color vision testing.
13| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 2/5 | Eye care remains a traditional, human-intensive clinical field with slower digital transformation than tech or finance sectors. Adoption of AI-driven diagnostic tools is still in early pilot phases in most ophthalmology and optometry practices. |
| Sector adoption velocity | claude-sonnet-5 | 1/5 | Ophthalmic/orthoptic clinical testing is a highly manual, physically-mediated healthcare service with minimal AI-driven displacement in current adoption patterns. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can assist orthoptists by automating measurement recording, flagging anomalies in test results, and suggesting follow-up tests, thereby reducing manual data entry and interpretation time. However, the core clinical judgment and patient interaction remain human-centered. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI-assisted image analysis, automated perimetry, and digital acuity charts can support interpretation and data recording, offering moderate productivity gains while the orthoptist still performs the hands-on testing. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While some diagnostic measurements (visual acuity, color vision testing) could be partially automated with specialized equipment and image analysis, the full task requires interpretation of results, patient interaction, and real-time adjustment of tests—capabilities that current AI systems lack. End-to-end automation with ≥50% time savings at equal quality is not achievable with off-the-shelf systems today. |
| Task automatability | claude-sonnet-5 | 1/5 | This requires hands-on physical manipulation of instruments, direct patient interaction, and real-time clinical judgment during testing that current AI cannot perform end-to-end without a human physically conducting the exam. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Regulatory bodies (FDA, state boards) require licensed practitioners (orthoptists or optometrists) to perform or validate diagnostic testing; liability for misdiagnosis falls on credentialed professionals. Legal and regulatory frameworks create a strong barrier to full automation without human sign-off. |
| Adoption barriers | claude-sonnet-5 | 5/5 | Orthoptists are licensed/certified clinical professionals, and diagnostic testing on patients typically requires credentialed personnel and physical presence, creating strong regulatory and liability barriers to automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Specialized diagnostic equipment plus AI integration, maintenance, and clinical validation costs are substantial, while orthoptist wages are moderate. The all-in cost per diagnostic session would remain competitive with or exceed human labor, especially when factoring in setup and calibration overhead. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | AI cannot substitute for the physical apparatus operation and patient interaction, so there is no viable AI-only cost comparison; a trained human with specialized equipment remains necessary. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | Some narrow diagnostic components (e.g., automated acuity charts, color blindness screening apps) exist in research or limited production, but no mature product reliably performs the full suite of motor, acuity, lensometry, retinoscopy, and color vision testing as an orthoptist would. Clinical deployment of end-to-end diagnostic testing remains limited and error-prone. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed product autonomously performs hands-on ocular motor testing, retinoscopy, or lensometry on patients; existing AI tools assist with image interpretation only, not the physical test administration. |
Develop nonsurgical treatment plans for patients with conditions such as strabismus, nystagmus, and other visual disorders.
13CI 0–25 · exposure 13 · augmentation 50 · importance 4.8/5 · click for rater detail
Develop nonsurgical treatment plans for patients with conditions such as strabismus, nystagmus, and other visual disorders.
13| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 1/5 | Orthoptics is a specialized, small clinical field with limited digitization and high dependence on licensed human expertise; AI adoption in this space remains minimal and slow. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Allied health/vision care is a modestly digitized clinical sector with slow, cautious AI adoption for diagnostic/treatment decisions, mostly limited to imaging analysis pilots rather than treatment planning. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can meaningfully assist orthoptists by summarizing visual test results, flagging anomalies in binocular measurements, and suggesting evidence-based treatment options, which would raise efficiency without removing human judgment from final plan development. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI can assist by summarizing clinical literature, analyzing eye-tracking or imaging data, and suggesting standard treatment protocols, but the orthoptist must integrate this into individualized plans. |
| Task automatability | claude-haiku-4-5-20251001 | 2/5 | While AI can assist in analyzing visual test data and suggesting treatment frameworks, developing individualized nonsurgical treatment plans requires real-time assessment of patient anatomy, visual acuity nuances, and adaptive clinical judgment that current systems cannot reliably replicate end-to-end. |
| Task automatability | claude-sonnet-5 | 1/5 | Developing a nonsurgical treatment plan for strabismus or nystagmus requires clinical examination, patient-specific judgment, and ongoing adjustment that current AI cannot perform end-to-end. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Strong barriers exist: only licensed orthoptists are legally authorized to diagnose and develop treatment plans for visual disorders in most jurisdictions, and liability for treatment failure rests on the licensed practitioner, not automation. |
| Adoption barriers | claude-sonnet-5 | 5/5 | Treatment planning for eye movement disorders is a licensed clinical activity requiring examination and accountability, with strong regulatory and liability barriers to non-human execution. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | Current AI systems require substantial integration, validation, and clinician oversight for orthoptic treatment planning, making the all-in cost comparable to or higher than direct orthoptist time for most real-world deployments. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | There is no viable AI substitute performing this task, so any AI cost comparison is moot; the human specialist remains the only real option, making AI relatively more 'expensive' due to absence of a functional alternative. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | No deployed product independently develops treatment plans for orthoptic conditions in production settings; AI support for decision-making exists in research and limited prototypes, but clinical responsibility remains with licensed orthoptists. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed product independently generates orthoptic treatment plans in clinical practice; this remains a specialist clinician function performed after hands-on assessment. |
Provide training related to clinical methods or orthoptics to students, resident physicians, or other health professionals.
13CI 9–16 · exposure 5 · augmentation 63 · importance 4.2/5 · click for rater detail
Provide training related to clinical methods or orthoptics to students, resident physicians, or other health professionals.
13| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 1/5 | Medical education remains one of the slowest sectors to adopt AI-led autonomous instruction due to accreditation requirements, credentialing standards, and cultural emphasis on human mentorship in clinical fields. Pilots exist but production substitution is minimal. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare education is a highly regulated, in-person-dependent sector with slow, cautious AI adoption limited mostly to supplementary e-learning tools. |
| Augmentation potential | claude-haiku-4-5-20251001 | 3/5 | AI can assist orthoptist instructors by generating study materials, organizing case libraries, or supporting virtual simulations, moderately improving their instructional capacity. However, the core task of live teaching and mentoring relies heavily on human judgment and presence, limiting transformative augmentation. |
| Augmentation potential | claude-sonnet-5 | 4/5 | AI can meaningfully augment training via generating case studies, quizzes, simulations, and personalized review materials, enhancing but not replacing the human instructor. |
| Task automatability | claude-haiku-4-5-20251001 | 1/5 | Clinical training and orthoptics instruction require live demonstration, real-time feedback on student performance, adaptive explanation based on learner response, and mentorship—capabilities that current AI systems cannot reliably deliver end-to-end. While AI could generate educational materials, it cannot substitute for the interactive, personalized instruction inherent to clinical teaching. |
| Task automatability | claude-sonnet-5 | 1/5 | Clinical training involves live demonstration, hands-on supervision, and adaptive mentorship that current AI cannot perform end-to-end despite being able to supply supplementary materials. |
| Adoption barriers | claude-haiku-4-5-20251001 | 4/5 | Medical education and clinical training are heavily regulated; instructors must be licensed or credentialed, and accreditation bodies require human faculty oversight of student instruction. Liability and educational governance create strong legal and organizational barriers to full automation. |
| Adoption barriers | claude-sonnet-5 | 4/5 | Clinical education typically requires certified/licensed practitioners to supervise and sign off on trainee competency, creating strong regulatory and accreditation barriers to full automation. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 2/5 | The cost of integrating and maintaining AI tutoring systems, combined with required human oversight and validation in medical education, remains comparable to or exceeds the cost of a qualified orthoptist instructor, especially given the low-volume, specialized nature of orthoptics training. |
| Cost vs. human wage | claude-sonnet-5 | 2/5 | While AI-generated study content is cheap, the actual clinical supervision and hands-on teaching still require paid expert time, so overall cost savings are minimal. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | No deployed product reliably delivers clinical orthoptics training autonomously. AI systems can assist with content generation and simulation support, but no production system actually performs the full teaching role with the necessary precision and responsiveness that medical training demands. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed AI product independently trains students or residents in orthoptic clinical methods; at best AI serves as a study aid or quiz tool alongside human instructors. |
Provide nonsurgical interventions, including corrective lenses, patches, drops, fusion exercises, or stereograms, to treat conditions such as strabismus, heterophoria, and convergence insufficiency.
4CI 0–7 · exposure 5 · augmentation 38 · importance 4.9/5 · click for rater detail
Provide nonsurgical interventions, including corrective lenses, patches, drops, fusion exercises, or stereograms, to treat conditions such as strabismus, heterophoria, and convergence insufficiency.
4| Dimension | Model | Rating | Rationale |
|---|---|---|---|
| Sector adoption velocity | claude-haiku-4-5-20251001 | 1/5 | Orthoptics is a specialized clinical field with limited digitization and a small practitioner base; adoption of AI automation is negligible because the work is hands-on, patient-dependent, and embedded in regulated medical practice with no production-scale AI deployment. |
| Sector adoption velocity | claude-sonnet-5 | 2/5 | Healthcare, especially allied health specialties like orthoptics, adopts AI slowly due to regulatory, safety, and reimbursement constraints; digital therapeutics are emerging but not deeply embedded. |
| Augmentation potential | claude-haiku-4-5-20251001 | 2/5 | AI could modestly assist with analyzing diagnostic images, tracking symptom records, or suggesting exercise protocols to present to the orthoptist, but the core intervention—fitting devices, evaluating binocular function, and adapting treatment—remains human-centric with limited AI augmentation potential. |
| Augmentation potential | claude-sonnet-5 | 3/5 | AI-based apps and gamified stereogram/fusion exercises can support home practice and monitoring adherence, providing useful augmentation to orthoptist-directed treatment plans. |
| Task automatability | claude-haiku-4-5-20251001 | 1/5 | This task requires in-person clinical assessment, hands-on fitting of corrective devices, real-time patient interaction to evaluate response, and skilled judgment about which intervention to prescribe—none of which current AI can perform end-to-end. AI cannot physically fit lenses, apply patches, or conduct fusion exercises with a patient. |
| Task automatability | claude-sonnet-5 | 1/5 | This is hands-on clinical treatment requiring physical examination, prescription of devices, and patient-specific therapeutic decisions that AI cannot physically deliver or fully determine end-to-end today. |
| Adoption barriers | claude-haiku-4-5-20251001 | 5/5 | Orthoptists are licensed regulated professionals; most jurisdictions legally require a licensed orthoptist or physician to prescribe corrective interventions and supervise treatment. Patient safety, liability for fitting errors, and regulatory scope of practice create hard barriers to substitution. |
| Adoption barriers | claude-sonnet-5 | 5/5 | This is licensed clinical practice involving diagnosis and treatment planning for medical conditions, requiring credentialed practitioners and carrying liability for vision-affecting errors. |
| Cost vs. human wage | claude-haiku-4-5-20251001 | 1/5 | The task involves hands-on clinical care, device fitting, and customized treatment that cannot be automated with current AI, so cost comparison is not favorable; the human orthoptist remains necessary for the complete service delivery. |
| Cost vs. human wage | claude-sonnet-5 | 1/5 | AI cannot independently deliver the physical exams, device fittings, or in-person exercise supervision, so no viable cost substitution exists; any AI use is supplementary to human labor cost. |
| Technical feasibility today | claude-haiku-4-5-20251001 | 2/5 | While AI can assist with diagnostic image analysis or educational content about strabismus, no deployed product can independently recommend and implement the full intervention protocol. Clinical decision-making requires live patient examination, binocular assessment, and adaptive titration that remains entirely human-performed today. |
| Technical feasibility today | claude-sonnet-5 | 1/5 | No deployed product administers nonsurgical strabismus/vergence treatments; digital vision therapy apps exist but are adjuncts, not autonomous replacements for orthoptist-directed care. |
Related occupations — Healthcare Practitioners & Technical
How to read this
A high substitution score does not mean this job disappears — it means a large share of its current tasks face replacement pressure, so the mix of tasks is likely to change. High augmentation alongside substitution typically means the occupation reorganizes around the protected tasks. Wide confidence intervals mean the rater panel disagreed: treat those scores as open questions, not verdicts.
What would change this score
New model capabilities (automatability, feasibility), falling inference costs (cost ratio), regulation and licensing shifts (barriers), and measured sector adoption (velocity) all re-enter at every index release. Each release is recomputed, versioned and kept queryable — scores are claims with a date on them, not permanent labels.